 |
|
|
|
Novartis is one of the world's leading healthcare companies. We are committed to improving the well being of people by creating innovative products and services in the areas of pharmaceuticals, nutrition, eye-care, and animal health. Each year, Novartis Pharmaceuticals Canada conducts clinical trials at hundreds of sites across the country, involving thousands of patients, researchers and investigators. Novartis has developed a broad competence in many therapeutic areas through wholly-owned interests, partnerships and strategic alliances. The combined research and development capabilities and experience available through this synergy have strengthened the Company's expertise and broadened its scientific scope, particularly in the field of dermatology. Innovative products include Apligraf ® for the treatment of venous leg ulcers, Lamisil ® for skin and nail fungal infections, Neoral ® for psoriasis and Famvir ® , which is the leader in the oral antiviral market and is the only antiviral indicated to reduce the duration of post herpetic neuralgia when used to treat herpes zoster. Novartis Pharmaceuticals Canada Inc. introduced in 2003 Elidel ® (Pimecrolimus) cream 1%, a new non-steroid, anti-inflammatory cream, effective in the treatment of mild to moderate atopic dermatitis both children and adults.
Click here to close this window |
